Allpharm Ltd in Bristol, BS34 6BQ

Description

Data updated on: 01-11-2023

This Allpharm Ltd business has been operating on the market for 8 years, as it's been established in 2017. Registered under the number 11020713, Allpharm was set up as a Private Limited Company located in Concord Medical Centre Braydon Avenue, Bristol BS34 6BQ. This company's SIC and NACE codes are 47730: Dispensing chemist in specialised stores. Allpharm Limited released its account information for the period up to March 31, 2022. The most recent annual confirmation statement was submitted on October 18, 2022.

We have a team of three directors running this specific business right now, specifically Simon B., James C. and Jane W. who have been doing the directors tasks since October 2017.

Executives who have control over this firm are as follows: Jane W. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Simon B. owns 1/2 or less of company shares and has 1/2 or less of voting rights. James C. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31	2024-03-31
Currency

Balance Sheet
Cash Bank On Hand	3	3	3	110 147	104 606	88 589
Current Assets	381 299	377 476	428 745	396 922	438 499	437 726
Debtors	292 034	309 996	368 650	236 627	288 292	295 325
Net Assets Liabilities	-246 292	-319 459	-295 385	-226 449	-230 681	-193 039
Property Plant Equipment	194 346	173 313	151 904	133 206	116 450	101 497
Total Inventories	89 262	67 477	60 092	50 148	45 601	53 812

Other Financial Data
Accrued Liabilities	2 936	10 199	23 191	47 071	65 897	97 109
Accrued Liabilities Deferred Income	90 032	114 234	105 862	102 934	110 037	120 379
Accumulated Amortisation Impairment Intangible Assets	49 583	92 083	134 583	178 004	224 186	270 369
Accumulated Depreciation Impairment Property Plant Equipment	26 385	50 264	71 673	90 535	107 291	122 244
Average Number Employees During Period	10	10	10	10	10	8
Bank Borrowings	550 151	599 244	620 618	572 984	517 382	470 870
Bank Borrowings Overdrafts	39 152	390 285	381 736	331 569	137 815	226 956
Corporation Tax Payable						2 656
Creditors	510 999	557 452	577 760	525 196	468 799	418 804
Fixed Assets	569 763	506 230	442 321	391 250	328 312	267 176
Increase From Amortisation Charge For Year Intangible Assets	49 583		42 500	43 421	46 182	46 183
Increase From Depreciation Charge For Year Property Plant Equipment	26 385		21 409	18 862	16 756	14 953
Intangible Assets	375 417	332 917	290 417	258 044	211 862	165 679
Intangible Assets Gross Cost	425 000	425 000	425 000	436 048	436 048
Net Current Assets Liabilities	-305 056	-268 237	-159 946	-92 503	-90 194	-22 879
Nominal Value Shares Issued Specific Share Issue	1
Number Shares Issued Fully Paid	3		3	3	3	3
Number Shares Issued Specific Share Issue	3
Other Creditors		131 319	131 762	131 604	97 020	1 219
Other Taxation Social Security Payable	-2 949	1 438	3 001	3 360	-2 878	6 419
Par Value Share	1		1	1	1	1
Prepayments	1 321	2 506	2 523	1 876	1 786	5 632
Profit Loss						37 642
Property Plant Equipment Gross Cost	220 731	223 577	223 577	223 741	223 741
Provisions For Liabilities Balance Sheet Subtotal						18 532
Recoverable Value-added Tax	13 054
Total Additions Including From Business Combinations Intangible Assets	425 000			11 048
Total Additions Including From Business Combinations Property Plant Equipment	220 731			164
Total Assets Less Current Liabilities	264 707	237 993	282 375	298 747	238 118	244 297
Trade Creditors Trade Payables	327 843	262 702	256 493	152 095	189 480	177 159
Trade Debtors Trade Receivables	277 659	307 490	366 127	234 751	286 506	289 693

Company staff

Simon B.

Role: Director

Appointed: 18 October 2017

Latest update: 15 May 2025

James C.

Role: Director

Appointed: 18 October 2017

Latest update: 15 May 2025

Jane W.

Role: Director

Appointed: 18 October 2017

Latest update: 15 May 2025

People with significant control

Jane W.

Notified on 18 October 2017

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Simon B.

Notified on 18 October 2017

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

James C.

Notified on 18 October 2017

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	01 November 2023
Confirmation statement last made up date	18 October 2022

Annual Accounts
Start Date For Period Covered By Report	18 October 2017
End Date For Period Covered By Report	31 March 2019
Annual Accounts
Start Date For Period Covered By Report	01 April 2020
End Date For Period Covered By Report	31 March 2021
Annual Accounts
Start Date For Period Covered By Report	01 April 2021
End Date For Period Covered By Report	31 March 2022
Annual Accounts
Start Date For Period Covered By Report	01 April 2022
End Date For Period Covered By Report	31 March 2023
Annual Accounts
Start Date For Period Covered By Report	01 April 2023
End Date For Period Covered By Report	31 March 2024

Allpharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Simon B.

James C.

Jane W.

People with significant control

Jane W.

Simon B.

James C.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode